Rapid receptive field (RF) reorganization of somatosensory neurons in the rat dorsal horn was examined using extracellular single unit recording. Subcutaneous injection of lidocaine into RFs of dorsal horn neurons results in expansion of their RFs within minutes. The expanded RFs appear adjacent to or/and proximal to original RFs. Out of 63 neurons tested, 36 (58%) show RF reorganization. The data suggest that dorsal horn of spinal cord is one of the initial sites for RF reorganization. The neural mechanisms of this effect are not well understood. We propose that changes in biophysical properties (membrane conductance, length constant) of the neurons resulting from lidocaine injection contribute to RF reorganization. Iontophoretic application of glutamate onto dorsal horn neurons that show lidocaine induced RF's expansion were used to test the model. Application of glutamate produced reduction of reorganized RFs in 9 of 20 (45%) tested cells. Application of NBQX produced no effect on either original or expanded RFs indicate that RF shrinkage effects of glutamate involve NMDA receptors. The results are consistent with the prediction of the proposed model. Subcutaneous injection of capsaicin into tactile RFs of low threshold mechanoreceptive dorsal horn neurons produced no effect on the RF sizes that are consistent with other studies. Following the injection, the original RFs were completely silenced (46%) or remained responsive (54%).

The first nociceptive synapse in the spinal cord dorsal horn represents an important site, where nociceptive synaptic transmission can be modulated under pathological conditions. One of the modulatory mechanism involves activation of the transient receptor potential vanilloid 1 (TRPV1) that is expressed on central terminals of primary nociceptive neurons, where it regulates release of neurotransmitters and neuromodulators. Previous studies suggested that changes in TRPV1 activity may be related to effects of chemokine CCL2 (C-C motif ligand 2) and may be also involved in synaptic transmission modulation after µ-opioid receptors (MOP-R) activation. Because CCL2 receptors CCR2 often co-localize with TRPV1 and MOP-R, the goal of this work was to studypossible interactions of these receptors on the pre-synaptic endings of primaryafferents in the spinal cord dorsal horn and their role in nociceptive signalling under pathological conditions. The presented thesis focused on the effect of CCL2 during peripheral neuropathy and its interference with µ-opioid receptor activation. To studysynaptic transmission at the spinal cord level, patch-clamp recordings of excitatory post-synaptic currents (EPSC) in superficial spinal cord dorsal horn neurons in acute lumbar spinal cord slices from rats was used....

Les glucocorticoïdes (GC) sont des hormones stéroïdes synthétisées par les glandes surrénales. La production de ces GC est une des réponses de l’organisme pour rétablir l’homéostasie grâce à différentes actions comprenant des effets centraux sur le comportement et la douleur. C’est ce dernier qui a fait l’objet de mes travaux dans le cadre de cette thèse.Les afférences sensorielles primaires véhiculent les informations de la périphérie dans les cornes dorsales de la moelle épinière. Ces informations qui peuvent être nociceptives sont modulées par un réseau de neurones spinal avant d’être transmises et intégrées. Nous avons montré que les GC sont impliqués dans la maturation et le fonctionnement de la transmission inhibitrice faisant intervenir le neurotransmetteur GABA. Dans les cornes dorsales, cette inhibition est cruciale pour limiter les mécanismes de transmission de l’information nociceptive. / Glucocorticoids (GC) are steroid hormones synthesized in adrenals following HPA axis activation. GC production is a response of the organism to alleviate homeostasis perturbations through different actions. One of them involves central neuronal modulation of behavior and pain perception.Primary afferents convey peripheral sensory information in the dorsal horns of the spinal cord. This information can be nociceptive and are modulated by a spinal neuronal network before being transmitted and integrated. We showed that GC are implied in the maturation and functioning of the inhibitory transmission involving GABA neurotransmitter. In the dorsal horns this inhibitory transmission is of major importance, limiting the processing of nociceptive information.

L’acétylcholine (ACh) endogène de la corne dorsale de la moelle épinière (CDME) exerce une analgésie puissante utilisée en clinique, dont la source et les mécanismes demeurent inconnus. Elle siège probablement au niveau d’un plexus de fibres cholinergiques de la CDME d’origine non-élucidée. Dans ce contexte, nous avons pu établir que ce plexus est principalement issu d’interneurones cholinergiques spinaux caractérisés dans ces travaux, qui seraient donc le substrat probable de l’analgésie décrite. Décrits comme concourant aux effets aigus et analgésiques de la morphine, nous avons, par ailleurs, pu observer que les récepteurs de l’ACh participaient également aux effets chroniques et pro-algésique de la morphine, notamment au niveau de la CDME. Ceci place donc l’ACh comme un effecteur ou intermédiaire de la morphine.Nos travaux suggèrent ainsi que le système cholinergique spinal pourrait constituer une cible thérapeutique alternative pour de nouveaux traitements de la douleur / In the spinal cord dorsal horn (SCDH), endogenous acetylcholine (ACh) acts as a powerful analgesia, of clinical use. Though its source and mechanisms remain unravelled, this analgesia probably lies in a plexus of cholinergic fibers (PCF) located in the SCDH and of undetermined origin. In this context, we established that the PCF mainly originates from a spinal population of cholinergic interneurons, fully characterized in this work. These are, thus, the likely substrate of the spinal cholinergic analgesia.Besides, ACh receptors (AChR) partly mediate the analgesic acute effects of morphine. In this work, we also observed that a chronically-administered AChR agonist reproduces as well the pro-algesic effects of morphine in the same conditions. Thus, ACh appears as a possible intermediary or a final effecter of the morphine pain pathways.Our data suggest that the cholinergic system could become a new putative therapeutic target in pain management and treatment.